Pilot Study of the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff
Two-Arm, Single Blind, Randomized Pilot Study on the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff
1 other identifier
interventional
82
1 country
4
Brief Summary
The primary objective of this study is to obtain safety data on the use of the ULTRABRAID PLUS SUTURE, and to assess the preliminary effectiveness of the use of the ULTRABRAID PLUS SUTURE in comparison to the ULTRABRAID SUTURE in patients undergoing rotator cuff repair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2013
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2013
CompletedFirst Posted
Study publicly available on registry
January 14, 2013
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedOctober 6, 2017
October 1, 2017
3.8 years
January 9, 2013
October 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rotator Cuff Integrity
The primary endpoint of the 6-month postoperative analysis is to assess rotator cuff integrity at 6 months, defined as the proportion of subjects with a re-tear of the rotator cuff as measured by high-resolution ultrasound.
6 months post-operatively
Secondary Outcomes (8)
Rotator Cuff Integrity
1, 3 and 6 weeks and 3 and 12 months post-operatively
Change in post-surgery tissue thickness, rotator cuff integrity, tendon echogenicity and muscle atrophy
1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Change in Vascularity
1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Change in Constant Shoulder Assessment
1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Change in Western Ontario Rotator Cuff Index
1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
- +3 more secondary outcomes
Study Arms (2)
ULTRABRAID PLUS SUTURE
EXPERIMENTALULTRABRAID Plus Suture manufactured by Smith \& Nephew used in subjects undergoing rotator cuff repair.
ULTRABRAID SUTURE
ACTIVE COMPARATORULTRABRAID Suture is a marketed suture manufactured by Smith \& Nephew used in subjects undergoing rotator cuff repair.
Interventions
Eligibility Criteria
You may qualify if:
- Male or female, aged 18 to 70 years at the time of surgery
- Willing and able to give voluntary informed consent to participate in this investigation
- Small (\<1cm), Medium (1-3cm) or large (\>3-5cm) tear of the supraspinatus tendon, which may or may not include the infraspinatus tendon of the rotator cuff. Tear size will be based on area of longest dimension as evidenced by clinical examination and diagnostic imaging prior to surgery, with the definitive measurement confirmed at surgery
- Tear requires repair within two years of initial diagnosis
- Tear must be anatomically repairable (must be able to get tendon back to the medial position on the footprint and at least back to the tuberosity)
- Willing and able, in the opinion of the Investigator, to cooperate with study procedures, and willing to return to study site for physical therapy and all post-operative study visits
You may not qualify if:
- Tears involving tendons other than the supraspinatus and infraspinatus
- Partial thickness tears of the rotator cuff (tear must be full thickness)
- Evidence of acute trauma including fracture or dislocation of the shoulder joint
- Chronic retraction
- Evidence of active infection, osteomyelitis, sepsis or distant infection which could spread to the index joint
- Subject has had previous rotator cuff, arthroplasty or fracture procedures on the operative shoulder
- Subject has had acromioplasty or diagnostic arthroscopy on the operative shoulder within one (1) year prior to scheduled surgery date
- Evidence of osteomalacia or other metabolic bone disorder(s) which may impair bone or soft tissue function
- Evidence of other significant shoulder pathology including (Type II-IV lesion, Bankart lesion, Hill Sachs lesion)
- Patient has grade 4 changes to articular cartilage in operative shoulder
- Inflammatory arthropathies
- Significant muscle paralysis of the shoulder girdle.
- Painful pathologies of the cervical spine
- Comminuted bone surface, which would compromise secure anchor fixation.
- Subject has a known sensitivity to implant materials, including sodium butyrate.
- +15 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Innovation Science and Medicine
Burlington, Ontario, L7R 4C7, Canada
Fowler Kennedy Sport Medicine Clinic
London, Ontario, N6A 3K7, Canada
St. Josephs Hospital
London, Ontario, N6A 4L6, Canada
Women's College Hospital
Toronto, Ontario, M5C 1R6, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Litchfield, MD, FRCSC
Fowler Kennedy Sports Medicine Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2013
First Posted
January 14, 2013
Study Start
February 1, 2013
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
October 6, 2017
Record last verified: 2017-10